We specialize in Chemistry, Manufacturing and Controls (CMC) regulatory affairs, with extensive expertise in authoring and reviewing Module 3 and Module 2.3 (Quality Overall Summary) dossiers for both commercial and development-stage products. Our team is equally proficient in Drug Substance and Drug Product regulatory submissions, including NDA, ANDA, BLA, MAA, IND, and Japan-specific filings such as JNDA, DMF, PCN, MCN, and AFM/FMA registrations.
Beyond initial submissions, our post-approval lifecycle management capabilities ensure that your products remain compliant and competitive after launch. We handle Type I and Type II Variations, CBE-0/CBE-30/PAS submissions, Post Approval Change Management Protocols (PACMP), manufacturing site transfers, and responses to health authority questions — keeping your product lifecycle running without interruption.
We also offer GMP compliance support, including audit preparation, inspection readiness, review of analytical method validations, batch manufacturing records, and manufacturing process validation documentation. Our quality compliance work helps clients maintain the highest standards of pharmaceutical manufacturing across global markets.
At ReguLinx, we do not believe in one-size-fits-all solutions. Every client and every product is unique. We invest time in understanding your regulatory history, product profile, and target markets before designing a tailored strategy that maximizes your chances of rapid, clean approval.
Our mission is simple: to reduce the time between pharmaceutical innovation and patient access by providing world-class regulatory guidance that is efficient, compliant, and strategically sound.
Our Mission
To accelerate the availability of safe, effective medicinal products to patients worldwide through expert, efficient, and ethical regulatory affairs support.
Our Vision
To be the most trusted global partner for pharmaceutical regulatory affairs — known for scientific rigor, strategic insight, and exceptional client outcomes.
Our Values
- Integrity: We operate with full transparency and honesty in every engagement.
- Excellence: We deliver work of the highest regulatory and scientific standard.
- Partnership: We work as an extension of your team, not just an outside vendor.
- Accountability: We take ownership of timelines, deliverables, and outcomes.
Our Journey
From our beginnings supporting single-market regulatory submissions to managing multi-regional filings simultaneously across FDA, EMA, PMDA, and other major health authorities, ReguLinx has grown steadily by delivering results. Today, we serve clients ranging from emerging biotech startups to established multinational pharmaceutical companies — across small molecules, biologics, vaccines, rare diseases, and large molecules.
